On Invalid Date, Novan (NASDAQ: NOVN) reported Q1 2023 earnings per share (EPS) of -$0.54, up 23.94% year over year. Total Novan earnings for the quarter were -$14.12 million. In the same quarter last year, Novan's earnings per share (EPS) was -$0.71.
As of Q2 2023, Novan's earnings has grown year over year. Novan's earnings in the past year totalled -$32.05 million.
What was NOVN's revenue last quarter?
On Invalid Date, Novan (NASDAQ: NOVN) reported Q1 2023 revenue of $3.17 million up 64.21% year over year. In the same quarter last year, Novan's revenue was $1.93 million.
What was NOVN's revenue growth in the past year?
As of Q2 2023, Novan's revenue has grown 512.74% year over year. This is 443.52 percentage points higher than the US Biotechnology industry revenue growth rate of 69.21%. Novan's revenue in the past year totalled $24.92 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.